Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Selective PDE4 inhibitors discovered at Jouveinal presented at ACS meeting

Sep. 11, 1998

Texas Biotechnology announces positive data from phase IIa asthma study

Sep. 11, 1998

Dimethoxy quinazoline derivative WHI-P180 inhibits mast cell mediator release

Sep. 11, 1998

Schering-Plough prepares arylalkylamines as neurokinin antagonists

Sep. 10, 1998

Novel WHI compound inhibits 5-LO translocation in mast cells

Sep. 9, 1998

Bradykinin B2 antagonists in the pipeline at Fournier

Sep. 7, 1998

NK2 antagonist saredutant prevents NKA-induced bronchoconstriction in asthmatic subjects

Sep. 4, 1998

New neurokinin antagonists from Schering-Plough especially useful for asthma

Sep. 3, 1998

Cheil Jedang discloses PDE IV inhibitors for treating asthma

Sep. 1, 1998

More alpha2-adrenoceptor agonists in the pipeline at Procter & Gamble

Sep. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...